BMO Commercial Banking Provides $10MM in Non-Dilutive Capital to Cannara Biotech
Cannara Biotech raised an additional $10 million of credit facilities from its lead bank, BMO Commercial Banking, via a $5 million increase to its term loan facility and a $5 million increase in its revolving line of credit.
May 5, 2023
BMO Commercial Banking | Cannara Biotech | Nicholas Sosiak
Ian Koplin